Skip to main content
SpringerLink
Log in

Health Canada has authorised the release of one lot (1500 doses) of the bladder cancer treatment ImmuCyst [BCG, sub-strain Connaught]

  • Media release
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Health Canada.Information Update - Review Determines ImmuCyst Lot Can be Released for Use Media Release: 14 Sep 2012. Available from: URL: http://www.hc-sc.gc.ca

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Health Canada has authorised the release of one lot (1500 doses) of the bladder cancer treatment ImmuCyst [BCG, sub-strain Connaught]. React. Wkly. 1420, 4 (2012). https://doi.org/10.2165/00128415-201214200-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214200-00015

Keywords

Search

Navigation